Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 23 Apr 21 424B4 Prospectus supplement with pricing info
- 22 Apr 21 EFFECT Notice of effectiveness
- 21 Apr 21 FWP Free writing prospectus
- 21 Apr 21 POS AM Prospectus update (post-effective amendment)
- 21 Apr 21 EFFECT Notice of effectiveness
-
14 Apr 21 S-1/A IPO registration (amended)
- 24 Mar 21 S-1 IPO registration
NPCE similar filings
Filing view
External links
Exhibit 99.1
CONSENT OF DIRECTOR NOMINEE
Pursuant to Rule 438 of Regulation C promulgated under the Securities Act of 1933, as amended (the “Securities Act”), in connection with the Registration Statement on Form S-1 (the “Registration Statement”) of NeuroPace, Inc., the undersigned hereby consents to being named and described as a person who will become a director of NeuroPace, Inc. in the Registration Statement and any amendment or supplement to any prospectus included in such Registration Statement, any amendment to such Registration Statement or any subsequent Registration Statement filed pursuant to Rule 462(b) under the Securities Act and to the filing or attachment of this consent with such Registration Statement and any amendment or supplement thereto.
IN WITNESS WHEREOF, the undersigned has executed this consent as of the 6th day of April, 2021.
/s/ Rakhi Kumar | ||
Name: Rakhi Kumar |